Autoimmune disease affects health in several ways leading to many complications in several various parts of the body such as brain, heart, nerves, glands and kidneys. Genetic and environment factors such as toxic chemicals, infections and dietary components are responsible for increasing prevalence of different autoimmune diseases like rheumatoid arthritis (RA), inflammatory bowel disease (IBD), celiac disease (CD), multiple sclerosis (MS), hepatitis, systemic lupus erythematous (SLE), type 1 diabetes (IDDM), and autoimmune thyroiditis (AT). The disease pattern of AID is still not fully explored, which makes diagnosis of the disease difficult and developing treatments as well as clinical trials becomes challenging. In 2012, National Institute of Health (NIH) estimated around 23.5 million people in the U.S. are affected with an autoimmune disease. Moreover, in 2017, according to the Department of Health and Human Services, in the top 10 list of popular health topic, autoimmune disease (AID) ranked first. Growing awareness among people regarding autoimmune disease and its complications is projected to support growth of the global autoimmune disease treatment market.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/895
Development in the treatment of autoimmune disease (AID) is expected to propel growth of growth of the global autoimmune disease treatment market. For instance, in 2016, a team of scientists at Perelman School of Medicine discovered a way to treat Pemphigus vulgaris (PV) autoimmune disease by targeting a particular subset of antibody responsible for PV. The team developed a chimeric autoantibody receptor therapy (CAART) to treat the disease without disturbing healthy immune system.
Similarly, in 2016, scientists from Cumming School of Medicine created a new Nano-medicine for treatment of multiple sclerosis, type 1 diabetes and rheumatoid arthritis without harming immunity.
Moreover, increasing cases of AIDs is creating demand for novel methods in treatment of the disease including biomarker, genetic research, and stem cell research, which in turn is expected to fuel growth of the global autoimmune disease treatment market. In 2017, the American Autoimmune Related Disease Association (AARDA) estimated autoimmune disease affected around 50 million people in the U.S.
Furthermore, investment in R&D activities by government and pharmaceutical companies to develop new medicines and treatments is expected to drive growth of the global autoimmune disease treatment market.
Rise in the number of chronic infections and diseases in low and middle-income countries is also expected to boost growth of the global autoimmune disease treatment market. For instance, in 2015, BioMed Central reported the increase in chronic infections and disorders such as SLE related to pregnancy causes obstetric, maternal and fatal complications.
However, high cost of AID therapy is expected to hamper growth of the global autoimmune disease treatment market.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/895
By Disease Types:
By Drug Type:
Nonsteroidal anti-inflammatory drugs
Major players active the global autoimmune disease treatment market are Abbott Laboratories, Eli Lilly and Company, Pfizer, Inc. Lupin Limited, Amgen, Inc., Bristol-Myers Squibb, Johnson & Johnson, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, AutoImmune Inc., AstraZeneca plc, 4SC AG, and Active Biotech.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/895
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Autoimmune Disease Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Autoimmune Disease Treatment Industry Impact
Chapter 2 Global Autoimmune Disease Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Autoimmune Disease Treatment (Volume and Value) by Type
2.3 Global Autoimmune Disease Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Autoimmune Disease Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Autoimmune Disease Treatment Market Analysis
Chapter 6 East Asia Autoimmune Disease Treatment Market Analysis
Chapter 7 Europe Autoimmune Disease Treatment Market Analysis
Chapter 8 South Asia Autoimmune Disease Treatment Market Analysis
Chapter 9 Southeast Asia Autoimmune Disease Treatment Market Analysis
Chapter 10 Middle East Autoimmune Disease Treatment Market Analysis
Chapter 11 Africa Autoimmune Disease Treatment Market Analysis
Chapter 12 Oceania Autoimmune Disease Treatment Market Analysis
Chapter 13 South America Autoimmune Disease Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Autoimmune Disease Treatment Business
Chapter 15 Global Autoimmune Disease Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027